Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus.

Gesk S, Klapper W, Martín-Subero JI, Nagel I, Harder L, Fu K, Bernd HW, Weisenburger DD, Parwaresch R, Siebert R.

Blood. 2006 Aug 1;108(3):1109-10. No abstract available.

2.

Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.

Wlodarska I, Dierickx D, Vanhentenrijk V, Van Roosbroeck K, Pospísilová H, Minnei F, Verhoef G, Thomas J, Vandenberghe P, De Wolf-Peeters C.

Blood. 2008 Jun 15;111(12):5683-90. doi: 10.1182/blood-2007-10-118794. Epub 2008 Apr 7.

3.

Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.

Chuang SS, Huang WT, Hsieh PP, Tseng HH, Campo E, Colomer D, Ye H, Lu CL, Chang HM, Cho CY, Huang SH, Lu YC, Wu JD.

Pathol Int. 2006 Aug;56(8):440-8.

PMID:
16872438
4.

Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression.

Herens C, Lambert F, Quintanilla-Martinez L, Bisig B, Deusings C, de Leval L.

Blood. 2008 Feb 1;111(3):1745-6. doi: 10.1182/blood-2007-10-120824. No abstract available.

5.

Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected.

Stefancikova L, Moulis M, Fabian P, Falkova I, Vasova I, Kren L, Macak J, Smardova J.

J Clin Pathol. 2009 Oct;62(10):948-50. doi: 10.1136/jcp.2008.063701.

PMID:
19783727
6.

Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR.

Quintanilla-Martinez L, Slotta-Huspenina J, Koch I, Klier M, Hsi ED, de Leval L, Klapper W, Gesk S, Siebert R, Fend F.

Haematologica. 2009 Nov;94(11):1595-8. doi: 10.3324/haematol.2009.010173. Epub 2009 Jul 16.

7.

CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.

Salaverria I, Royo C, Carvajal-Cuenca A, Clot G, Navarro A, Valera A, Song JY, Woroniecka R, Rymkiewicz G, Klapper W, Hartmann EM, Sujobert P, Wlodarska I, Ferry JA, Gaulard P, Ott G, Rosenwald A, Lopez-Guillermo A, Quintanilla-Martinez L, Harris NL, Jaffe ES, Siebert R, Campo E, Beà S.

Blood. 2013 Feb 21;121(8):1394-402. doi: 10.1182/blood-2012-08-452284. Epub 2012 Dec 18.

8.

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.

Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, De Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, Dave BJ, Sanger WG, Smith LM, Rimsza L, Braziel RM, Müller-Hermelink HK, Campo E, Gascoyne RD, Staudt LM, Chan WC; Lymphoma/Leukemia Molecular Profiling Project.

Blood. 2005 Dec 15;106(13):4315-21. Epub 2005 Aug 25.

9.

CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.

Shiller SM, Zieske A, Holmes H 3rd, Feldman AL, Law ME, Saad R.

Cancer Genet. 2011 Mar;204(3):162-4. doi: 10.1016/j.cancergencyto.2010.08.016.

PMID:
21504716
10.

Cyclin D1-negative mantle cell lymphoma.

Seto M.

Blood. 2013 Feb 21;121(8):1249-50. doi: 10.1182/blood-2013-01-475954.

11.
12.
13.

Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.

Metcalf RA, Zhao S, Anderson MW, Lu ZS, Galperin I, Marinelli RJ, Cherry AM, Lossos IS, Natkunam Y.

Mod Pathol. 2010 Mar;23(3):420-33. doi: 10.1038/modpathol.2009.173. Epub 2010 Jan 8.

14.

Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/delta locus in t(12;14)(p13;q11)-positive childhood T-cell acute lymphoblastic leukemia.

Karrman K, Andersson A, Björgvinsdóttir H, Strömbeck B, Lassen C, Olofsson T, Nguyen-Khac F, Berger R, Bernard O, Fioretos T, Johansson B.

Eur J Haematol. 2006 Jul;77(1):27-34. Epub 2006 Mar 17.

PMID:
16548914
15.

Variant t(2;11)(p11.2;q13) without IGK involvement in a case of mantle cell lymphoma.

Woroniecka R, Grygalewicz B, Pienkowska-Grela B, Rymkiewicz G, Konecki R, Swoboda P, Janik P.

Cancer Genet Cytogenet. 2007 Jun;175(2):154-8.

PMID:
17556072
16.

Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.

Tucker CA, Bebb G, Klasa RJ, Chhanabhai M, Lestou V, Horsman DE, Gascoyne RD, Wiestner A, Masin D, Bally M, Williams ME.

Leuk Res. 2006 Apr;30(4):449-57. Epub 2005 Sep 23.

PMID:
16183118
17.

Mantle cell lymphoma with triple-fusion signals of immunoglobulin heavy chain locus/cyclin D1 gene by fluorescence in situ hybridization.

Kuroda N, Taniguchi Y, Miyazaki E, Inagaki K.

Pathol Int. 2006 Aug;56(8):478-9. No abstract available.

PMID:
16872445
18.

Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma.

Sathanoori M, Shekhter-Levin S, Marks SM, Swerdlow SH.

Cancer Genet Cytogenet. 2007 Jan 15;172(2):158-64.

PMID:
17213026
19.

Mantle cell lymphoma with aberrant expression of CD10.

Zanetto U, Dong H, Huang Y, Zhang K, Narbaitz M, Sapia S, Kostopoulos I, Liu H, Du MQ, Bacon CM.

Histopathology. 2008 Jul;53(1):20-9. doi: 10.1111/j.1365-2559.2008.03060.x. Epub 2008 Jun 2.

PMID:
18518902
20.

Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma.

Liu H, Huang J, Wang J, Jiang S, Bailey AS, Goldman DC, Welcker M, Bedell V, Slovak ML, Clurman B, Thayer M, Fleming WH, Epner E.

J Exp Med. 2008 Aug 4;205(8):1843-58. doi: 10.1084/jem.20072102. Epub 2008 Jul 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk